205 related articles for article (PubMed ID: 14967414)
21. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.
Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH
J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836
[TBL] [Abstract][Full Text] [Related]
22. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
[TBL] [Abstract][Full Text] [Related]
23. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
24. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
Schumacher WA; Seiler SE; Steinbacher TE; Stewart AB; Bostwick JS; Hartl KS; Liu EC; Ogletree ML
Eur J Pharmacol; 2007 Sep; 570(1-3):167-74. PubMed ID: 17597608
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
Weijer S; Schoenmakers SH; Florquin S; Levi M; Vlasuk GP; Rote WE; Reitsma PH; Spek CA; van der Poll T
J Infect Dis; 2004 Jun; 189(12):2308-17. PubMed ID: 15181580
[TBL] [Abstract][Full Text] [Related]
27. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Hedner U; Erhardtsen E
Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
[TBL] [Abstract][Full Text] [Related]
28. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
29. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
[TBL] [Abstract][Full Text] [Related]
30. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
[TBL] [Abstract][Full Text] [Related]
31. Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
Young WB; Mordenti J; Torkelson S; Shrader WD; Kolesnikov A; Rai R; Liu L; Hu H; Leahy EM; Green MJ; Sprengeler PA; Katz BA; Yu C; Janc JW; Elrod KC; Marzec UM; Hanson SR
Bioorg Med Chem Lett; 2006 Apr; 16(7):2037-41. PubMed ID: 16412633
[TBL] [Abstract][Full Text] [Related]
32. Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.
Gruber A; Carlsson S; Kotzé HF; Marzec U; Sarich TC; Hanson SR
Thromb Res; 2007; 119(1):121-7. PubMed ID: 16448687
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human blood.
Hernandez MR; Tonda R; Pino M; Serradell M; Arderiu G; Escolar G
Eur J Clin Invest; 2004 Apr; 34(4):297-302. PubMed ID: 15086362
[TBL] [Abstract][Full Text] [Related]
34. Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
Bird E; Tamura J; Bostwick JS; Steinbacher TE; Stewart A; Liu Y; Baumann J; Feyen J; Tamasi J; Schumacher WA
Thromb Res; 2007; 120(4):549-58. PubMed ID: 17229457
[TBL] [Abstract][Full Text] [Related]
35. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
36. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties.
Stassen JM; Lambeir AM; Matthyssens G; Ripka WC; Nyström A; Sixma JJ; Vermylen J
Thromb Haemost; 1995 Aug; 74(2):646-54. PubMed ID: 8585001
[TBL] [Abstract][Full Text] [Related]
38. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
[TBL] [Abstract][Full Text] [Related]
39. A newly developed oral heparin derivative for deep vein thrombosis: non-human primate study.
Kim SK; Lee DY; Kim CY; Nam JH; Moon HT; Byun Y
J Control Release; 2007 Nov; 123(2):155-63. PubMed ID: 17884230
[TBL] [Abstract][Full Text] [Related]
40. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]